Abstract
AbstractPatient-tailored silicone plug for HeartMate 3™ left ventricular assist device explantation in two successive males proceeded successfully. Given medical therapeutic advancements, FDA-approved plug systems designed by LVAD manufacturers themselves will be necessary for the near future to provide a safe and simple device explantation alternative that fulfills all regulatory standards.
Funder
Universitätsklinikum Erlangen
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Biomedical Engineering,Biomaterials,Medicine (miscellaneous)
Reference5 articles.
1. Dandel M, Hetzer R. Myocardial recovery during mechanical circulatory support: long-term outcome and elective ventricular assist device implantation to promote recovery as a treatment goal. Heart Lung Vessels. 2015;7:289–96.
2. Potapov EV, Politis N, Karck M, et al. Results from a multicentre evaluation of plug use for left ventricular assist device explantation. Interact Cardiovasc Thorac Surg. 2022;34:683–90. https://doi.org/10.1093/icvts/ivab344.
3. Elbayomi M, Weyand M, Seitz T, Heim C, Steger K, Tandler R. Recovery of a dilated left ventricle after cessation of cocaine and HVADTM explantation using a titanium plug. J Card Surg. 2022. https://doi.org/10.1111/jocs.17135.
4. Topkara VK, Garan AR, Fine B, et al. Myocardial recovery in patients receiving contemporary left ventricular assist devices. Circ Heart Fail. 2016;9: e003157. https://doi.org/10.1161/CIRCHEARTFAILURE.116.003157.
5. Antonides CFJ, Schoenrath F, de By TMMH, et al. Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study. ESC Heart Fail. 2020;7:1085–94. https://doi.org/10.1002/ehf2.12629.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献